JEAN CAIN: Open Payments
NPI 1558404319 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,450 in 89 payments from 7 companies in 2025. Trend: 2023 $44,030 · 2024 $57,115 · 2025 $41,450
Speaker / faculty: $29,025Travel & lodging: $7,209Consulting: $3,000Food & beverage: $2,196Education: $19
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 42 | $26,901 |
| TG Therapeutics, Inc. | 13 | $9,999 |
| Genentech USA, Inc. | 6 | $3,741 |
| Alexion Pharmaceuticals, Inc. | 1 | $525 |
| Novartis Pharmaceuticals Corporation | 23 | $213 |
| Amgen Inc. | 3 | $53 |
| Celgene Corporation | 1 | $18 |
Products named: Mavenclad, BRIUMVI, Ocrevus, ULTOMIRIS, KESIMPTA, UPLIZNA, ZEPOSIA.
Industry payments across PA — which companies pay providers there.
